News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
About the Author - Mark Terry

BioSpace News - By Mark Terry
What You Need to Know About Oncorus 1/20/2017
What You Need to Know About Decibel Therapeutics 1/20/2017
McKesson Pharma (MCK) to Pink Slip Some Employees in Wisconsin, Effective March 31 1/20/2017
NIH Director to Keep Job Under Trump, for Now 1/20/2017
Theranos' Last Defender Claims Federal Witch Hunt 1/20/2017
Who Might or Might Not Buy Regeneron (REGN), And Why 1/20/2017
A Peek Behind the Curtain of the Ariad (ARIA)-Takeda (TKPYY) Deal 1/20/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III 1/20/2017
GlaxoSmithKline (GSK) Poaches AstraZeneca PLC (AZN) Exec to Replace Exiting Pharma Head 1/19/2017
Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry 1/19/2017
5 Biotechs and the Drugs That May Put Them in Trump's Disfavor 1/19/2017
Calling All Scientists: 7 Things You Need to Know About Paid Biotech Internships 1/19/2017
9 Tips to Create the Best Clinical Research Resume or CV 1/19/2017
Anonymous Short Trader Attacks Cellceutix (CTIX) Again 1/19/2017
What You Need to Know About Ideaya 1/19/2017
What You Need to Know About Morphic Therapeutic 1/19/2017
What Trump and His Potential Nominees Should Understand About the FDA 1/19/2017
Massachusetts' CoLucid Pharma (CLCD) Surges on $960 Million Eli Lilly (LLY) Buyout Deal 1/19/2017
Pfizer (PFE) CEO: What Trump Doesn't Understand About Pharma 1/19/2017
2017 Could be The Breakout Year for These 5 Biotechs 1/18/2017
Battered Ophthotech (OPHT) Cuts 80% of Staff After Failed Clinical Trials 1/18/2017
Meet the 27-Year Old CEO Who's Running Biotech Visikol 1/18/2017
Tiny Forward Pharma (FWP) Rockets on $1.25 Billion Cash Deal With Biogen (BIIB) 1/18/2017
Time to Get on the Train: 3 Biotechs That are About to Have Its Breakout Moment 1/18/2017
What You Need to Know About Adicet Bio 1/18/2017
What You Need to Know About Codiak BioSciences 1/18/2017
Genentech (RHHBY) Dealt a Blow From Massachusetts' Highest Court 1/17/2017
What You Need to Know About Tioma Therapeutics 1/17/2017
What You Need to Know About Blade Therapeutics 1/17/2017
Google (GOOG)'s Verily Pumps 1.4 Billion Euros Into Ireland; Expansion to Create 400 New Jobs 1/17/2017
Newly Created Fibrocor Therapeutics Makes Debut 1/17/2017
New Spinraza Data Has Biogen (BIIB) Screaming 'It's Worth It!' 1/16/2017
JPM17: Surprise! Pfizer (PFE) is Still Deal Hungry for M&As After Medivation (MDVN) 1/16/2017
What You Need to Know About GRAIL 1/16/2017
What You Need to Know About Petra Pharma 1/16/2017
Here's a Look at Allergan (AGN)'s Opportunity in NASH 1/16/2017
Struggling Nivalis (NVLS) Cuts 80% of Staff, Including CEO and CMO 1/13/2017
What You Need to Know About Forty Seven 1/13/2017
What You Need to Know About Semma Therapeutics 1/13/2017
Meet AstraZeneca PLC (AZN)'s New Head of Oncology 1/13/2017
3 Little-Known Drugmakers That Deserve More Attention 1/13/2017
Takeda (TKPYY) Takes a $125 Million+ Chance, Seals an Option to Buy Bay Area Startup Maverick Therapeutics 1/12/2017
After Ariad (ARIA), These 3 Drug Cancer Firms Could be Taken Out Next 1/12/2017
JPM17: Biotech IPO Guru Vivek Ramaswamy Expects More Startups, Deals in 2017 1/12/2017
What You Need to Know About Neon Therapeutics 1/12/2017
What You Need to Know About Denali 1/12/2017
What You Need to Know About Arcus Biosciences 1/12/2017
JPM17: Sarepta (SRPT)'s New Numbers Impress Investors, Stock Gained $300 Million Overnight 1/11/2017
What You Need to Know About C4 Therapeutics 1/11/2017
JPM17: How Celgene (CELG) Wowed Yet Again 1/11/2017
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials 1/11/2017
Daiichi Sankyo to Shutter Indian R&D Center, 170 Employees Affected 1/11/2017
On a Roll: Kite Pharma (KITE) Bags $250 Million CAR-T Deal From Daiichi Sankyo, Forms Joint Venture With Fosun Pharma 1/11/2017
How Ariad (ARIA)'s Price Hikes Resulted in a $5 Billion Payday for Investors 1/10/2017
Cambridge's Merrimack (MACK) Slashes 80% of Workforce, Sells Off Cancer Drugs in $1.025 Billion Deal 1/10/2017
JPM17: Vertex (VRTX) Game Plan for Growth in 2017 1/10/2017
This German Biotech Just Inked a $1 Billion+ Cancer Deal With Biotech Giant Amgen (AMGN) 1/10/2017
Takeda (TKPYY) Swallows Up Struggling Ariad (ARIA) in $5.2 Billion Deal 1/10/2017
What You Need to Know About Homology Medicines 1/9/2017
What You Need to Know About Fulcrum Therapeutics 1/9/2017
What You Need to Know About Arrivo BioVentures 1/9/2017
What You Need to Know About Pliant 1/9/2017
Gilead (GILD)'s New Hire Fuels Talk of an Acquisition 1/9/2017
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/9/2017
This is Why Actelion (ALIOF.PK) Canceled Its Appearance at the J.P. Morgan Conference Next Week 1/6/2017
5 Biotechs That Could be Big Takeover Targets in 2017 1/6/2017
Rumors Have Pfizer (PFE) Eyeing This SoCal Biotech 1/6/2017
Cambridge's Momenta (MNTA) Jumps on $600 Million R&D Pact With This Global Biotech 1/6/2017
13 Reasons to Watch the J.P. Morgan Healthcare Conference Next Week 1/6/2017
Tiny Boston Biotech Pieris Nabs $570 Million+ Cancer Deal With French Powerhouse Servier 1/6/2017
How to Use These Top 6 Unique Interview Tips to Get Your Next Life Science Job 1/5/2017
Massachusetts Startup Neon Therapeutics Rakes in $70 Million for Personalized Cancer Vaccines 1/5/2017
3 Quiet Biotechs Ready to Make Some Noise in 2017 1/4/2017
A Look Into Billionaire Dr. Phillip Frost's Risky Biotech Portfolio 1/4/2017
Novartis AG (NVS) Rumored to Be Buying Intercept Pharma (ICPT) 1/4/2017
7 Juicy Acquisition Targets in Biopharma for 2017 1/4/2017
Nivalis (NVLS) Begins Exploring Strategic Alternatives and Streamlining Ops After Clinical Trial Setback 1/4/2017
Listen Up Researchers: Versant Ventures to Fund 2 Dozen Biotech Startups With $400 Million 1/4/2017
How Allergan (AGN) CEO's New Model Will be Tested in 2017 1/3/2017
7 Biotech Companies With Key FDA Decisions or Catalysts in January and February 2017 1/3/2017
Phase III Flop for Pfizer (PFE)'s Drug Partner Opko Health (OPK) 1/3/2017
Cambridge-Based Jounce Files for $75 Million IPO 1/3/2017
FDA Approval of Aurobindo (AUROPHARMA.BO)'s Two Drugs Sends Stock Up 1/3/2017
Crown Bioscience Sets Up New U.S. Pharma Subsidiary and Creates Jobs With $70K Salaries 12/30/2016
FDA Rejects Cempra (CEMP)'s NDAs for Solithromycin, Shares Sink 12/30/2016
4 Fatal Deaths in Seattle Genetics (SGEN)' Early-Stage Trials of AML Drug 12/30/2016
Anthera Pharma (ANTH) Plunges After Cystic Fibrosis Drug Fails Late-Stage Trial 12/29/2016
3 Headwinds AbbVie (ABBV) Faces in 2017 12/29/2016
Bay Area Biotech Nabs $50 Million Cash Upfront in Partnership Expansion With Vifor Pharma 12/29/2016
The Last Week Of 2016 Could Be Big For These 9 Biotech Catalysts 12/28/2016
Inside Stock Purchases Hint That Abbott (ABT) Deals Will Be Resolved 12/28/2016
Taking a Shot on Who Might Buy Incyte (INCY) in 2017 12/28/2016
SoCal Essentialis and Bay Area Biotech to Merge and Form Newly Combined Company 12/28/2016
Beware: Rapes Alleged at Genentech (RHHBY) by Janitorial Contractor 12/28/2016
These 3 Biotech Stocks Are Better Buys Than Gilead (GILD) 12/27/2016
2017 is Make-or-Break for This Biotech 12/22/2016
Sun Pharma (SUNPHARMA.NS) to Acquire Cancer Product from Novartis AG (NVS) for $175 Million 12/22/2016
Battle for Actelion (ALIOF.PK): Sanofi (SNY) is Out, Johnson & Johnson (JNJ) is Back In 12/22/2016
Introducing the Newly Formed OticPharma 12/22/2016
This Biotech Forges $200+ Million Research Pact With Incyte (INCY) 12/22/2016
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January 12/22/2016
Investors Grow Impatient With Sanofi (SNY) and Actelion (ALIOF.PK) Over Acquisition and Possible Contingent Value Right 12/21/2016
Former Sanofi (SNY) and Lupin Pharmaceuticals, Inc. Execs Jump to Endo International (ENDP) 12/21/2016
Allergan (AGN) Dives Deep into $2.9 Billion Cash Deal With New Jersey Biotech 12/21/2016
Launched in 2015 with $45 Million, Bay Area Revolution Medicines Scores $25 Million 12/21/2016
3 Cheap Biotech Stocks Ready to Rock 12/21/2016
Newly Formed Company Established by Pluristem Therapeutics (PSTI) and Sosei CVC 12/20/2016
Newly Formed Company Gains Celgene (CELG), Versant Ventures Backing 12/20/2016
This Year’s 5 Most Expensive Drugs, Plus One 12/20/2016
Wellcome Trust Sanger Institute Spins Out New Company Microbiotica 12/19/2016
Concordia (CXR.TO) Kills Phase III Trial, Terminates Contract Sales, and Leaves Nasdaq Biotech Index 12/19/2016
Here's Why Amgen (AMGN), Celgene (CELG), and Gilead (GILD) Like These Small Biotechs 12/19/2016
Meet the Man Who Was Just Named Genentech (RHHBY)'s New CEO 12/19/2016
Novartis AG (NVS) Snaps Up Mid-Stage Eczema Rival 12/19/2016
Cambridge Biotech Agios (AGIO) Terminates AG-519 for PK Deficiency, But Continues AG-348 For Same Condition 12/19/2016
Pfizer (PFE)'s Xtandi Flunks Late-Stage Study Against Johnson & Johnson (JNJ)'s Zytiga 12/16/2016
3 Biggest Risks Ahead for Celgene (CELG) 12/16/2016
Biogen (BIIB) Ends the Year by Slashing Another 200+ Jobs as It Exits Manufacturing in Massachusetts 12/16/2016
Digging Deeper on Why Johnson & Johnson (JNJ) Abandoned the Actelion (ALIOF.PK) Acquisition 12/15/2016
A Look Into Mysterious Moderna's Amazing But Still Untested Technology 12/15/2016
Bristol-Myers Squibb (BMY) to Shut Down Three Sites by 2020 But Will Expand in New Jersey and Massachusetts 12/15/2016
Cambridge Startup Goldfinch Bio Launches With $55 Million and Will be Helmed by Former Eleven Bio (EBIO) Exec 12/15/2016
Investors Sigh With Relief as Biogen (BIIB)'s Alzheimer's Drug Delivers in Early-Stage Study 12/15/2016
Johnson & Johnson (JNJ) Walks and Sanofi (SNY) Steps in to Woo Actelion (ALIOF.PK) 12/14/2016
How This Tiny Bay Area Biopharma Could be a Million-Maker Stock 12/14/2016
Meet the 21-Year-Old College Student Who's Running Biotech Startup Genetesis 12/13/2016
Many of Sanofi (SNY) Diabetes Layoffs Likely to be in Massachusetts 12/13/2016
Changing of the Guard at Valeant (VRX) as 3 Execs Leave and New Dermatology Head Arrives 12/13/2016
Sanofi (SNY) to Cut 20 Percent of its U.S. Diabetes Workforce 12/12/2016
Plans Terminated, Google Ventures Ex-Boss Pulled the Plug on the $230 Million Healthcare Venture Capital Fund 12/12/2016
3 Biotech Stocks Resistant Trump's Twitter Tirades 12/12/2016
Meet the 34-Year Old Scientist Who's Transforming CRISPR 12/12/2016
Bayer (BAY), Versant Ventures Launch BlueRock Therapeutics With $225 Million to Focus on Stem Cell R&D 12/12/2016
As Biogen (BIIB)'s Drug Shines, Eli Lilly (LLY) Releases Detailed Results of Its Own Failure Solanezumab 12/9/2016
Gilead (GILD)'s 3 Biggest Goofs of 2016 12/9/2016
These Biotech CEOs Made the Biggest Blunders of 2016 12/9/2016
All Eyes Will Be on Biogen (BIIB) and Its Much-Anticipated Alzheimer's Data Tomorrow 12/9/2016
Cambridge Biotech TCR2 Therapeutics Launches From Stealth Mode With $44.5 Million 12/8/2016
Baxter International (BAX) Cuts Jobs at Indiana Facility 12/7/2016
Meet the 5 Superstar Scientists Who Just Won the 'Oscars of Science' From Silicon Valley Tech Billionaires 12/7/2016
Why Biogen (BIIB) Could Rebound in 2017 12/7/2016
Biopharma Manufacturing Jobs to Double 12/6/2016
Johnson & Johnson (JNJ) Feels the Competition as Sanofi (SNY) May Throw Hat In the Ring for Actelion (ALIOF.PK) 12/6/2016
A Look at Gilead (GILD) and Its Potential $10 Billion Blunder 12/6/2016
Boston's Acetylon Gets Taken Out By Celgene (CELG), Will Spin Out Startup Regenacy Pharma 12/6/2016
Google Ventures Ex-Boss Raising $230 Million to Start Healthcare Venture Capital Fund 12/6/2016
Boehringer Ingelheim to Slash Another 180 Jobs Weeks Before the Holidays 12/5/2016
AstraZeneca PLC (AZN) to Shift an Unknown Number of Jobs to Other Countries in Cost-Cutting Move 12/5/2016
As Rival Juno (JUNO) Falters, Kite Pharma (KITE) Touts New CAR-T Data and Maps Out BLA Submission Plans 12/5/2016
Roaring Intellia Moves Into New HQ, Allowing Company to Double Staff and Advance CRISPR/Cas9 Pipeline 12/5/2016
Tiny Bicycle Therapeutics Snags a Drug Discovery Pact Worth $1 Billion With AstraZeneca PLC (AZN) 12/2/2016
Pros and Cons of Pfizer (PFE) Buying Exelixis (EXEL) 12/2/2016
Cerevance Launches With $36 Million and 25 Former Takeda (TKPYY) Employees on Its Roster 12/2/2016
Biotech Jobs Driven by Digital Tech, Are You Ready? 12/1/2016
SoCal's Arrowhead Pharma (ARWR) Stock Craters After Terminating 30% of Workforce, Discontinuing Work on Lead Hep B Drugs 12/1/2016
Fear of Layoffs Loom Over Eli Lilly (LLY) Employees After Alzheimer's Setback 12/1/2016
Valeant (VRX)'s $10 Billion Salix (SLXP) Deal With Takeda (TKPYY) Falls Apart 12/1/2016
A Look at the Top 5 Biotech Stock Performers of 2016 11/30/2016
Warp Drive Bio Hands Over Antibiotics Program to Sanofi (SNY) 11/30/2016
Actelion (ALIOF.PK) Falls as the 'It's Complicated' Tag Gets Slapped on Relationship With Johnson & Johnson (JNJ) 11/29/2016
Actavis (ACT) to Slash 200 Workers as Part of Teva (TEVA)'s Consolidation Efforts 11/29/2016
5 Biotechs That Have Potential Catalysts By the End of the Year 11/29/2016
3 Reasons Big Hedge Funds Dropped Allergan (AGN) Like a Hot Potato in Q3 11/29/2016
Devastation Hits as Eli Lilly (LLY)'s Alzheimer's Drug Flunks Late-Stage Study, Shares Tank 11/29/2016
Johnson & Johnson (JNJ) Makes a Play for This $19.9 Billion Swiss Biotech 11/29/2016
Investors Remain Bullish Over Biogen (BIIB)'s Risky Alzheimer's Drug Despite Eli Lilly (LLY) Setback 11/28/2016
5 Beaten-Down Biotech Stocks Billionaire Financier George Soros Bought in Q3 11/28/2016
The Franchise That Could Bring in Another $20 Billion for Celgene (CELG) 11/23/2016
Pfizer (PFE) to Consolidate St. Louis Offices at New $200 Million+ Facility, Will Keep 450 Jobs 11/23/2016
5 Drug Giants That Could Dominate the $13 Billion Alzheimer's Market 11/23/2016
Reeling From GlobeImmune (GBIM) Hepatitis B Termination, Gilead (GILD) Faces Merck & Co. (MRK), GlaxoSmithKline (GSK) Competition 11/22/2016
Novartis AG (NVS) and Google (GOOG)’s Verily Miss Smart Contact Lens Human Trial Goal 11/22/2016
Novartis AG (NVS) Scoops Up U.S. Sickle Cell Drugmaker Selexys in $665 Million Deal 11/22/2016
7 Reasons Scientists are Terrified About Donald Trump's Presidency 11/21/2016
What You Need to Know Before Taking a Biotech Startup Job 11/21/2016
3 Stocks That May Appeal to New Biotech Investors 11/21/2016
Embattled GlobeImmune (GBIM) Loses Gilead (GILD) Deal, Cancels HQ Lease, and CEO Resigns 11/21/2016
Gilead (GILD)'s R&D Woes Could Make it an Attractive Target for Allergan (AGN) and Pfizer (PFE) 11/18/2016
Sanofi Pasteur (SASY.PA) Abandons Bladder Cancer Drug 11/18/2016
Here Are the Biotechs on Gilead (GILD)'s Holiday Shopping List 11/18/2016
Boehringer Ingelheim Will Move North American HQ to Georgia, Bulk of Employees Will Remain Unaffected 11/18/2016
Biopharma is Hungry for Data Scientists 11/18/2016
Investors Hold Their Breath for the "Most Important Event in Biotech"—Here are 5 Stocks to Watch 11/18/2016
Gilead (GILD) Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency 11/18/2016
4 Louisiana Biotech Startups to Put on Your Radar 11/17/2016
A Look at the Bay Area’s Proposed Biotech Hotel 11/16/2016
With Bristol-Myers Squibb (BMY), Genentech (RHHBY) and Merck & Co. (MRK) Expanding in the Bay Area, Some Wonder if the Real Estate Boom is Too Much 11/16/2016
5 Biopharma Influencers Likely to Be on Trump’s Transition Team 11/16/2016
5 Biotech Stocks Poised to Grow in Trumpworld 11/16/2016
uniQure (QURE) Shakes Up R&D to Refocus Pipeline, to Eliminate 20-25% of Workforce By End of 2017 11/15/2016
Cash to Operate a Growing Concern for Bay Area's VistaGen 11/15/2016
Why Pfizer (PFE) Should Take the Plunge in Selling or Spinning Off Its Consumer Healthcare Biz 11/15/2016
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro (TSRO) and Sarepta (SRPT) 11/15/2016
Novartis AG (NVS) Reportedly in Talks to Buy New Jersey's Amneal, Deal Could be Worth $8 Billion 11/15/2016
Meet the Woman That's Helming Bay Area's Calithera Biosciences (CALA) 11/14/2016
Genentech (RHHBY) Snaps Up Four Buildings it Had Been Leasing Since 2006 11/14/2016
Struggling Novavax (NVAX) Pink Slips 30% of Workforce and Retools Pipeline After Trial Flop 11/11/2016
Trump Promises to "Reform the FDA" in Post-Election Mission Statement 11/11/2016
Pfizer (PFE) May Sell or Spin Off Its $14 Billion Consumer Health Biz 11/10/2016
Pfizer (PFE) to Shutter Two UK Facilities and Lay Off 370 Over Four Years 11/9/2016